Preview Mode Links will not work in preview mode

GRACEcast


Mar 31, 2013

Dr. Oxnard from Dana Farber Cancer Institute provides his insight on which patients with advanced non-small cell lung cancer he pursues molecular testing for, and which molecular markers are the highest priority.